Toronto Dominion Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39,000
Closed -$41.9M 2277
2025
Q4
$41.9M Buy
+39,000
New +$37.3M 0.06% 285
2025
Q2
Sell
-3,300
Closed -$2.73M 1915
2025
Q1
$2.73M Buy
+3,300
New +$2.75M 0.01% 855
2024
Q3
Sell
-15,000
Closed -$13.6M 1322
2024
Q2
$13.6M Buy
+15,000
New +$12M 0.02% 410
2019
Q4
Sell
-90,000
Closed -$10.1M 1459
2019
Q3
$10.1M Buy
+90,000
New +$10M 0.02% 462

Other funds holding LLY

Toronto Dominion Bank's LLY Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $56.1M and leaving 329,370 shares worth $303M. The position accounts for 0.43% of the portfolio, ranked #43.

Toronto Dominion Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $413M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Toronto Dominion Bank held 329,370 shares of Eli Lilly worth $303M as of Q1 2026.
  • Toronto Dominion Bank sold 55,341 Eli Lilly shares in Q1 2026, an estimated $56.1M.
  • Eli Lilly made up 0.43% of Toronto Dominion Bank's portfolio in Q1 2026, its #43 holding.
  • Toronto Dominion Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Eli Lilly position peaked at $413M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.